Literature DB >> 17124512

Tuning inflammation and immunity by chemokine sequestration: decoys and more.

Alberto Mantovani1, Raffaella Bonecchi, Massimo Locati.   

Abstract

A set of chemokine receptors are structurally unable to elicit migration or conventional signalling responses after ligand engagement. These 'silent' (non-signalling) chemokine receptors regulate inflammatory and immune reactions in different ways, including by acting as decoys and scavengers. Chemokine decoy receptors recognize distinct and complementary sets of ligands and are strategically expressed in different cellular contexts. Importantly, viruses and parasites have evolved multiple strategies to elude chemokines, including the expression of decoy receptors. So, decoy receptors for chemokines represent a general strategy to tune, shape and temper innate and adaptive immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17124512     DOI: 10.1038/nri1964

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  166 in total

Review 1.  G protein-coupled receptors as therapeutic targets for multiple sclerosis.

Authors:  Changsheng Du; Xin Xie
Journal:  Cell Res       Date:  2012-06-05       Impact factor: 25.617

Review 2.  Functional role of chemokines in liver disease models.

Authors:  Hacer Sahin; Christian Trautwein; Hermann E Wasmuth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-26       Impact factor: 46.802

Review 3.  Oxidative stress and inflammation interactions in human obesity.

Authors:  Isabel Bondia-Pons; Lisa Ryan; J Alfredo Martinez
Journal:  J Physiol Biochem       Date:  2012-02-17       Impact factor: 4.158

4.  Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin.

Authors:  Keisuke Nagao; Tetsuro Kobayashi; Kazuyo Moro; Manabu Ohyama; Takeya Adachi; Daniela Y Kitashima; Satoshi Ueha; Keisuke Horiuchi; Hideaki Tanizaki; Kenji Kabashima; Akiharu Kubo; Young-hun Cho; Björn E Clausen; Kouji Matsushima; Makoto Suematsu; Glaucia C Furtado; Sergio A Lira; Joshua M Farber; Mark C Udey; Masayuki Amagai
Journal:  Nat Immunol       Date:  2012-06-24       Impact factor: 25.606

5.  In vivo structure/function and expression analysis of the CX3C chemokine fractalkine.

Authors:  Ki-Wook Kim; Alexandra Vallon-Eberhard; Ehud Zigmond; Julia Farache; Elias Shezen; Guy Shakhar; Andreas Ludwig; Sergio A Lira; Steffen Jung
Journal:  Blood       Date:  2011-09-27       Impact factor: 22.113

6.  Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer.

Authors:  Shi-Liang Gui; Li-Chen Teng; Shu-Qiu Wang; Shuang Liu; Ying-Li Lin; Xiao-Lian Zhao; Lei Liu; Hong-Yu Sui; Yang Yang; Li-Chun Liang; Mo-Lin Wang; Xin-Yi Li; Yu Cao; Feng-Ying Li; Wei-Qun Wang
Journal:  Int Urol Nephrol       Date:  2016-02-02       Impact factor: 2.370

7.  Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer.

Authors:  Zheng Liu; Yu Zhu; Le Xu; Junyu Zhang; Huyang Xie; Hangcheng Fu; Quan Zhou; Yuan Chang; Bo Dai; Jiejie Xu
Journal:  Oncoimmunology       Date:  2018-08-01       Impact factor: 8.110

8.  Targeting chemokine pathways in esophageal adenocarcinoma.

Authors:  Makardhwaj S Shrivastava; Zulfiqar Hussain; Orsolya Giricz; Niraj Shenoy; Rahul Polineni; Anirban Maitra; Amit Verma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.

Authors:  Marion Leick; Julie Catusse; Marie Follo; Robert J Nibbs; Tanja N Hartmann; Hendrik Veelken; Meike Burger
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

10.  Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta.

Authors:  L J Sandell; X Xing; C Franz; S Davies; L-W Chang; D Patra
Journal:  Osteoarthritis Cartilage       Date:  2008-06-18       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.